MedPath

Recombinant Zoster Vaccine (CHO cell)

Generic Name
Recombinant Zoster Vaccine (CHO cell)
Clinical Trials
Related News

Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older

Phase 1
Recruiting
Conditions
Herpes Zoster
Herpes Zoster Vaccine
Interventions
Biological: Recombinant zoster vaccine(CHO cell)(low adjuvant)
Biological: Zoster Vaccine, Live
Biological: Recombinant Zoster Vaccine (CHO cell) (Adjuvant control)
Biological: Normal Saline
First Posted Date
2025-02-28
Last Posted Date
2025-03-03
Lead Sponsor
Ab&B Bio-tech Co., Ltd.JS
Target Recruit Count
960
Registration Number
NCT06851832
Locations
🇨🇳

Xiangcheng County Center for Disease Control and Prevention, Xuchang, Henan, China

Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).

Phase 3
Not yet recruiting
Conditions
Herpes Zoster
Interventions
First Posted Date
2024-10-23
Last Posted Date
2024-11-20
Lead Sponsor
MAXVAX Biotechnology Limited Liability Company
Target Recruit Count
1200
Registration Number
NCT06654700
Locations
🇨🇳

Henan Center for Diseases Control and Prevention, Zhengzhou, Henan, China

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

Phase 3
Active, not recruiting
Conditions
Herpes Zoster
Interventions
Biological: NaCl solution Placebo
First Posted Date
2024-06-07
Last Posted Date
2024-10-24
Lead Sponsor
MAXVAX Biotechnology Limited Liability Company
Target Recruit Count
25000
Registration Number
NCT06447779
Locations
🇨🇳

Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China

🇨🇳

Henan Center for Diseases Control and Prevention, Zhengzhou, Henan, China

🇨🇳

Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy